Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Malik Fady Ibraham
Relationship:   EVP Research & Develop...
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   135,004    

Indirect Shares

  0      
Direct Value   $7,280,766    

Indirect Value

  $0      
Total Shares   135,004      
Total Value   $7,280,766      


Cytokinetics Inc
 $7,280,766 Cytokinetics Inc
 $7,280,766
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    7    

     Stock price went up :

    0   
    5    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   2.5   
     Percentage Gain/Loss :
     0.0%
 322.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cytokinetics Inc CYTK EVP Research & Develop... 2024-06-11 135,004 0    Premium*  
* Premium Members only  

Records found :    120         Free Registration Required For Full Results.    Limit: 25

Download
  Page 5 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2023-09-14 4 S $34.86 $87,150 D/D (2,500) 155,664 0 %
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2023-10-12 4 S $35.89 $89,725 D/D (2,500) 153,164 0 %
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2023-11-09 4 S $35.40 $88,500 D/D (2,500) 150,664 0 %
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-01-04 4 AS $86.98 $1,363,712 D/D (15,678) 146,973 0 %
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-01-04 4 OE $7.96 $92,957 D/D 11,678 162,651 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-02-06 4 OE $6.67 $190,795 D/D 28,605 175,578 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-02-06 4 AS $79.28 $2,585,497 D/D (32,605) 142,973 0 %
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-03-04 4 D $67.68 $651,758 D/D (9,630) 133,343 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-03-05 4 OE $6.67 $190,789 D/D 28,604 167,577 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-03-05 4 AS $67.53 $2,202,606 D/D (32,604) 138,973 0 %
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-03-06 4 D $66.88 $542,330 D/D (8,109) 121,234 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-03-14 4 A $0.00 $0 D/D 21,333 142,567 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-04-09 4 OE $6.67 $190,795 D/D 28,605 171,172 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-04-09 4 S $74.31 $2,422,918 D/D (32,605) 138,567 0 %
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-04-12 4 GD $0.00 $0 D/D 150 138,417 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-05-07 4 OE $6.67 $94,621 D/D 14,186 152,603 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-05-07 4 AS $65.11 $1,012,265 D/D (15,547) 137,056 0 %
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-06-11 4 OE $7.96 $43,159 D/D 5,422 142,792 0 -
CYTK Cytokinetics Inc EVP Research & Development   •       •      –    2024-06-11 4 S $53.03 $413,106 D/D (7,788) 135,004 0 %
CYTK Cytokinetics Inc SVP Research & Early DevOffice   •       –      –    2012-06-01 3 IO $0.00 $0 D/D 0 33,632 -

  120  Records found
  1   2   3   4   5     
  Page 5 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed